Segment Information (Tables)

3 Months Ended

Dec. 31, 2021

Segment Reporting [Abstract]

Segment Revenue, Operating (Loss) Income and Depreciation and Amortization

Segment revenue, operating (loss) income, and depreciation and amortization were as follows:

	Three Months Ended
	December 31,
(In thousands)	2021			2020
Revenue:
Medical Device	$	16,908		$	16,196
In Vitro Diagnostics		6,095			6,101
Total revenue	$	23,003		$	22,297
Operating (loss) income:
Medical Device	$	(3,792	)	$	(593	)
In Vitro Diagnostics		3,155			3,220
Total segment operating (loss) income		(637	)		2,627
Corporate		(2,804	)		(2,534	)
Total operating (loss) income	$	(3,441	)	$	93
Depreciation and amortization:
Medical Device	$	2,194		$	1,652
In Vitro Diagnostics		86			105
Corporate		96			103
Total depreciation and amortization	$	2,376		$	1,860